Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.37%14.96M | 2.31%17.08M | -5.66%57.56M | -14.26%13.04M | -12.73%15.3M | -16.98%12.53M | 26.62%16.7M | -0.30%61.02M | 9.21%15.2M | 13.35%17.54M |
| Cost of revenue | 12.91%12.12M | 6.68%13.29M | -2.33%34.61M | -11.61%10.78M | 1.48%13.01M | -8.74%10.73M | 24.31%12.46M | -11.42%35.43M | 359.60%12.19M | 9.54%12.82M |
| Gross profit | 57.99%2.84M | -10.52%3.79M | -10.27%22.96M | -25.00%2.26M | -51.32%2.3M | -46.08%1.8M | 33.92%4.24M | 20.66%25.59M | -73.27%3.01M | 25.19%4.72M |
| Operating expense | -20.76%2.54M | -17.59%2.42M | 4.82%15.6M | 22.35%2.8M | -13.70%2.56M | 13.86%3.2M | 19.17%2.93M | 5.85%14.88M | -60.74%2.29M | 3.06%2.96M |
| Staff costs | ---- | ---- | 2.63%12.09M | ---- | ---- | ---- | ---- | 3.78%11.78M | ---- | ---- |
| Selling and administrative expenses | -20.76%2.54M | -17.59%2.42M | 9.19%11.49M | 22.35%2.8M | -13.70%2.56M | 13.86%3.2M | 19.17%2.93M | --10.52M | --2.29M | 3.06%2.96M |
| -Selling and marketing expense | 11.84%1M | -5.72%956K | 0.60%3.84M | 40.41%952K | -10.25%981K | -21.49%895K | 11.67%1.01M | --3.82M | --678K | 10.96%1.09M |
| -General and administrative expense | -33.41%1.54M | -23.85%1.46M | 14.08%7.65M | 14.74%1.85M | -15.72%1.58M | 37.96%2.31M | 23.55%1.92M | --6.71M | --1.61M | -1.06%1.87M |
| Depreciation and amortization | ---- | ---- | 13.12%3.51M | ---- | ---- | ---- | ---- | 14.50%3.1M | ---- | ---- |
| -Depreciation | ---- | ---- | 13.45%3.51M | ---- | ---- | ---- | ---- | 15.19%3.09M | ---- | ---- |
| -Amortization | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -62.50%9K | ---- | ---- |
| Operating profit | 121.16%298K | 5.36%1.38M | -31.25%7.36M | -174.10%-538K | -114.73%-259K | -372.87%-1.41M | 85.51%1.31M | 49.83%10.7M | -86.67%726K | 96.21%1.76M |
| Net non-operating interest income (expenses) | -40.67%-211K | -39.22%-213K | -38.17%-676.32K | -20.86%-226K | -27.03%-188K | 0.66%-150K | -5.52%-153K | -3.75%-489.48K | -197.79%-187K | -9.63%-148K |
| Non-operating interest income | ---- | ---- | -70.25%40.94K | ---- | ---- | ---- | ---- | 41.45%137.63K | ---- | ---- |
| Non-operating interest expense | 40.67%211K | 39.22%213K | 14.38%717.26K | 20.86%226K | 27.03%188K | -0.66%150K | 5.52%153K | 10.19%627.11K | 16.81%187K | 9.63%148K |
| Net investment income | 118.52%408.3K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 52.00%38K | 144.44%22K | -18.63%99.39K | -84.21%3K | 44.19%62K | -16.67%25K | -70.00%9K | 72.59%122.14K | -8.51%19K | 65.38%43K |
| Special income (charges) | -81.87%219.77K | 809.86%1.21M | ||||||||
| Less:Other special charges | ---- | ---- | 57.53%-593.25K | ---- | ---- | ---- | ---- | -129,963.50%-1.4M | ---- | ---- |
| Less:Write off | ---- | ---- | 102.14%373.49K | ---- | ---- | ---- | ---- | 7.53%184.76K | ---- | ---- |
| Other non-operating income (expenses) | 115.13%327K | -23.38%118K | -13.59%-7.31M | -55.68%164K | 418.31%736K | -89.17%152K | -62.16%154K | -20.23%-6.43M | 106.21%370K | -5.33%142K |
| Income before tax | 132.73%452K | -0.99%1.3M | -105.55%-306.46K | -164.33%-597K | -80.45%351K | -176.81%-1.38M | 32.13%1.32M | 292.22%5.52M | 273.81%928K | 91.57%1.8M |
| Income tax | 85.50%486K | -16.41%219K | -70.12%833.05K | -97.75%43K | -58.82%266K | 78.23%262K | 204.65%262K | 239.43%2.79M | 401.80%1.91M | 27.92%646K |
| Net income | 97.93%-34K | 2.85%1.08M | -141.67%-1.14M | 34.76%-640K | -92.60%85K | -199.52%-1.64M | 15.82%1.05M | 366.15%2.73M | -7.29%-981K | 165.97%1.15M |
| Net income continuous operations | 97.93%-34K | 2.85%1.08M | -141.67%-1.14M | 34.76%-640K | -92.60%85K | -199.52%-1.64M | 15.82%1.05M | 366.15%2.73M | -7.29%-981K | 165.97%1.15M |
| Noncontrolling interests | 0.00%-8K | -2K | 72.46%-33.99K | 92.39%-7K | -66.67%-20K | 42.86%-8K | 0 | -156.37%-123.43K | -665.84%-92K | 90.48%-12K |
| Net income attributable to the company | 98.41%-26K | 3.04%1.09M | -138.68%-1.11M | 28.80%-633K | -90.96%105K | -198.20%-1.64M | 14.81%1.05M | 677.36%2.86M | 1.48%-889K | 108.06%1.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 98.41%-26K | 3.04%1.09M | -138.68%-1.11M | 28.80%-633K | -90.96%105K | -198.20%-1.64M | 14.81%1.05M | 677.36%2.86M | 1.48%-889K | 108.06%1.16M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 98.39%-0.0002 | -1.25%0.0079 | -136.68%-0.0084 | 32.39%-0.0048 | -91.30%0.0008 | -192.54%-0.0124 | 8.11%0.008 | 667.17%0.0229 | 2.94%-0.0071 | 104.44%0.0092 |
| Diluted earnings per share | 98.39%-0.0002 | -1.27%0.0078 | -137.33%-0.0084 | 32.39%-0.0048 | -91.30%0.0008 | -193.23%-0.0124 | 8.22%0.0079 | 667.92%0.0225 | 2.94%-0.0071 | 104.44%0.0092 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.